ClinicalTrials.gg
Drug

Doxylamine succinate clinical trials

A product of Doxylamine; its studies count on that page too.

studies test it
3
open now
0
in phase 3
1
first study started
2008

How each study uses doxylamine succinate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
7 Apr 1948 · DECAPRYN · NDA 006412 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

Studies by the year they started

3 studies that test it; most in 2008 (1)

Studies that test doxylamine succinate, by start year
YearStudies
20081
20191
20251

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 3
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 1

Bahria University (1) · Duchesnay Inc. (1) · Grünenthal GmbH (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses doxylamine succinate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Codes

What other systems call doxylamine succinate · ClinicalTrials.gg INT003049

  • MeSH (NLM) C035385doxylamine succinateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) V9BI9B5YI2DOXYLAMINE SUCCINATEConfirmed FDA, NLM, Wikidata
  • RxNorm 23665One source FDA
  • Wikidata Q72470509Doxylamine succinateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47501Doxylamine SuccinateOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.